Abbott Diabetes Care Inc. is the division of Abbott that develops the FreeStyle Libre family of continuous glucose monitoring (CGM) systems and companion mobile apps. Part of global healthcare company Abbott, the team focuses on tools that help people with diabetes see glucose readings, trends and actionable insights from a sensor worn on the body. Their mobile portfolio on this site includes FreeStyle Libre 2 - US, FreeStyle LibreLink - US and Libre by Abbott.
The group has been central to bringing factory-calibrated CGM technology into routine care, with FreeStyle Libre systems cleared for use by regulatory agencies in several markets. Abbott Diabetes Care pairs sensor hardware with app features such as real-time glucose checks, trend graphs, history and secure data sharing for care teams. Support and documentation are available through their site (https://www.FreeStyleLibre.com) and by email ([email protected]).
Their work is notable for shifting glucose monitoring away from fingersticks for many users and for building an ecosystem — sensors, readers and apps — that serves people with diabetes, caregivers and clinicians. The apps on this site reflect that ecosystem: tools that connect to Libre sensors, log events, and enable viewing and exporting of glucose data for review and treatment decisions.
